Session: 47. Transplant Infectious Diseases
Thursday, October 9, 2014: 12:30 PM Background. Cytomegalovirus (CMV) disease commonly occurs in lung transplant recipients after stopping anti-CMV prophylaxis. Its epidemiology is not wellstudied given difficulties in assembling representative study populations with prolonged follow-up. We hypothesized that delayed-onset CMV disease (> 100 days post-transplant) occurs more commonly than early-onset CMV disease in lung transplant recipients, and is associated with an increased risk of death.
Methods. We assembled a large cohort of lung transplant recipients using 2004 to 2010 ICD-9-CM billing data from 3 Agency for Healthcare Research and Quality (AHRQ) State Inpatient Databases (SID), and identified demographics, comorbidities, CMV disease coded during hospital readmission and inpatient death. We used Cox proportional hazard multivariable analyses to assess for an independent association between delayed-onset CMV disease and death.
Results. In the cohort of 1,528 lung transplant recipients from 12 transplant centers, delayed-onset CMV disease occurred in 13.7% (n = 210) and early-onset CMV disease occurred in 3.3% (n = 51). Delayed-onset CMV pneumonitis was associated with inpatient death > 100 days post-transplant (aHR 1.6, 95% CI 1.1-2.5), after adjusting for transplant failure or rejection (aHR 2.5, 95% CI 1.5-4.1), bacterial pneumonia (aHR 2.8, 95% CI 2.0-3.9), viral pneumonia (aHR 1.5, 95% CI 1.1-2.1), fungal pneumonia (aHR 1.8, 95% CI 1.3-2.3), single lung transplant (aHR 1.3, 95% CI 1.0-1.7) and idiopathic pulmonary fibrosis (aHR 1.4, 95% CI 1.0-1.8).
Conclusion. Delayed-onset CMV disease occurs more commonly than early-onset CMV disease among lung transplant recipients. These results suggest that delayedonset CMV pneumonitis is associated with an increased risk of death.
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